Stelo is the first over the counter (OTC) wearable glucose biosensor available without a prescription, suitable for people with type 2 diabetes not on insulin.
Mentions in press and media 5
| Date | Title | Description |
| 05.09.2024 | Dexcom's New Glucose Monitor: A Double-Edged Sword for Investors and Consumers | Dexcom has stepped into the spotlight with its latest product, Stelo, a continuous glucose monitor (CGM) now available over-the-counter. This move is a bold attempt to broaden its market reach beyond diabetes patients. The company aims to t... |
| 03.09.2024 | Health | Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs | Dexcom said the use of its continuous glucose monitors on its own or alongside other diabetes or weight management tools can help people understand how different foods or activities affect their glucose levels. When Dexcom announced the rol... |
| 28.08.2024 | DexCom's Stelo: A Game Changer for Glucose Monitoring | In a world where health is paramount, DexCom has stepped into the spotlight. The company recently launched Stelo, the first over-the-counter glucose biosensor in the United States. This innovation is a beacon of hope for millions grappling ... |
| 26.08.2024 | DexCom launches Stelo, first over-the-counter glucose biosensor in U.S., available without prescription | DexCom, a maker of real-time continuous glucose monitoring devices, announced today the availability of Stelo, the first over-the-counter glucose biosensor in the U.S., now purchasable without a prescription at Stelo.com. This new offering ... |
| 26.08.2024 | DexCom Launches Non-Prescription Glucose Biosensor in U.S. | What You Should Know: – Millions of Americans with Type 2 diabetes and prediabetes now have a new option for managing their glucose levels. – DexCom, a leader in continuous glucose monitoring (CGM) technology announced the launch of Stelo, ... |